Gusenbauer et al. (2013) [32] identified, via mass spectrometry, novel binding partners of TK-inactive EGFR, including AXL and EphA2 RTKs, and CDCP1 (CUB domain-containing protein), highlighting their roles in cancer progression. This evidence concerns the gene EGFR and cancer.